跳至主要内容
临床试验/JPRN-UMIN000029324
JPRN-UMIN000029324招募中未知

Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitis - Clinical trial of thalidomide for CGD colitis

ational Center for Child Heath and Development0 个研究点目标入组 8 人开始时间: 2017年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients allergic to the drug ingredients 2) Patients with HIV infection 3) Cancer except granuloma 4) Macrophage activating syndrome 5) Any mental problem 6) Pregnant or breast-feeding woman 7) Taking thalidomide or having a history of thalidomide administration 8) Oral, intravenous, or enema administration of steroid within four weeks of providing informed consent 9) Administration of immunomodulator within eight weeks of providing informed consent 10) A history of any biological agent administration 11) Miner who do not have guardian for appropriate administration of investigational agent 12) In certain circumstances that the researchers determined it was not suitable for the research

研究者

发起方
ational Center for Child Heath and Development

相似试验

Double-blind placebo-controlled clinical trial of... | 临床试验